Revolution Medicines, Inc. (RVMD)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch RVMD
See up to 3 months of RVMD. The 7-day demo opens the 1M and 3M ranges and puts RVMD on your watchlist.
Start 7-day demoLatest RVMD insider trades
About Revolution Medicines, Inc. (RVMD)
Revolution Medicines, Inc. files with the SEC under CIK 0001628171 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
RVMD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 79 | 380,710 | $78.01M |
| Option exercise | 18 | 504,730 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
RVMD insider transactions (Form 4)
79103 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Margaret A. Horn - Officer | Open-market sale | Common Stock | 4,847 | $76.82 | $372K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 3,104 | $77.09 | $239K | |
| Jack Anders - Officer | Option exercise | Stock Option (Right to Buy) | 5,418 | $0.00 | - | |
| Jack Anders - Officer | Option exercise | Common Stock | 5,418 | $17.00 | $92K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 5,418 | $74.00 | $401K | |
 Mark A. Goldsmith - Officer | Option exercise | Common Stock | 60,000 | $4.09 | $245K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 60,000 | $75.08 footnote F3 | $4.50M | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 3,000 | $75.00 | $225K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 3,000 | $75.00 | $225K | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 60,000 | $0.00 | - | |
| ||||||
| Jeff Cislini - Officer | Option exercise | Common Stock | 13,388 | $42.45 | $568K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 13,388 | $70.14 footnote F3 | $939K | |
| Jeff Cislini - Officer | Option exercise | Stock Option (Right to Buy) | 13,388 | $0.00 | - | |
| ||||||
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 20,000 | $4.09 | $82K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 20,000 | $70.38 footnote F3 | $1.41M | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
| ||||||
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 20,000 | $4.09 | $82K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 20,000 | $65.07 footnote F3 | $1.30M | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
| ||||||
| Jack Anders - Officer | Option exercise | Common Stock | 10,000 | $17.00 | $170K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 10,000 | $64.00 | $640K | |
| Jack Anders - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 30,000 | $60.31 footnote F4 | $1.81M | |
| Mark A. Goldsmith - Officer | Gift | Common Stock | 50,000 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Gift | Common Stock | 50,000 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Gift | Common Stock | 50,000 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Gift | Common Stock | 50,000 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 26,479 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 3,521 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 26,479 | $1.12 | $30K | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 3,521 | $4.09 | $14K | |
| ||||||
| Jeff Cislini - Officer | Option exercise | Common Stock | 12,000 | $36.57 | $439K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 12,000 | $55.00 | $660K | |
| Jeff Cislini - Officer | Option exercise | Stock Option (Right to Buy) | 12,000 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 10,000 | $50.47 footnote F3 | $505K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 10,000 | $55.00 | $550K | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 10,000 | $1.12 | $11K | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 10,000 | $1.12 | $11K | |
| ||||||
| Stephen Michael Kelsey - Officer | Option exercise | Common Stock | 25,000 | $4.73 | $118K | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 25,000 | $48.54 footnote F3 | $1.21M | |
| Stephen Michael Kelsey - Officer | Option exercise | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| ||||||
| Jeff Cislini - Officer | Open-market sale | Common Stock | 1,799 | $44.26 | $80K | |
| Lin Wei - Officer | Open-market sale | Common Stock | 2,160 | $45.82 | $99K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 2,320 | $45.82 | $106K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 1,869 | $45.82 | $86K | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 5,367 | $45.82 | $246K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 4,775 | $45.82 | $219K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 13,411 | $45.82 | $615K | |
| Stephen Michael Kelsey - Officer | Option exercise | Common Stock | 100,000 | $4.73 | $473K | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 44,059 | $43.58 | $1.92M | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 55,941 | $44.48 | $2.49M | |
| Stephen Michael Kelsey - Officer | Option exercise | Common Stock | 25,000 | $4.73 | $118K | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 23,682 | $45.92 | $1.09M | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 1,318 | $46.93 | $62K | |
| Stephen Michael Kelsey - Officer | Option exercise | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Stephen Michael Kelsey - Officer | Option exercise | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| Jack Anders - Officer | Option exercise | Common Stock | 2,814 | $2.68 | $8K | |
| Jack Anders - Officer | Option exercise | Common Stock | 1,948 | $4.73 | $9K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 4,762 | $40.02 | $191K | |
| Jack Anders - Officer | Option exercise | Common Stock | 3,189 | $4.73 | $15K | |
| Jack Anders - Officer | Option exercise | Common Stock | 2,049 | $17.00 | $35K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 5,238 | $40.17 | $210K | |
| Jack Anders - Officer | Option exercise | Stock Option (Right to Buy) | 2,814 | $0.00 | - | |
| Jack Anders - Officer | Option exercise | Stock Option (Right to Buy) | 1,948 | $0.00 | - | |
| Jack Anders - Officer | Option exercise | Stock Option (Right to Buy) | 3,189 | $0.00 | - | |
| Jack Anders - Officer | Option exercise | Stock Option (Right to Buy) | 2,049 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 37,000 | $0.54 | $20K | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 37,000 | $0.00 | - | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 3,510 | $39.83 | $140K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 13,496 | $39.83 | $538K | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 30,846 | $0.49 | $15K | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 30,846 | $0.00 | - | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 1,599 | $45.40 | $73K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 2,635 | $45.40 | $120K | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 4,663 | $45.40 | $212K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 4,329 | $45.40 | $197K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 11,714 | $45.40 | $532K | |
See every RVMD filing on record
These pages show the latest 90 of 103 Form 4 filings on record. The 7-day demo shows all 103, and sign-up brings you back to this table.
Item 2.03, 8.01
Item 1.01, 2.03
Item 8.01
Item 2.02, 9.01
Recent RVMD Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| ALAN SANDLER | Officer | 6,309 | $1.27M | View on EDGAR | |
| ANTHONY MANCINI | Officer | 9,363 |
RVMD insider trading FAQ
What is the latest insider trade for RVMD?
Revolution Medicines, Inc. (RVMD) had 18 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for RVMD runs to 103 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RVMD stock?
No insider purchases of RVMD were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling RVMD stock?
79 insider sales of RVMD were filed in the last 90 days, totaling $78.01M.
Where can I see RVMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RVMD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Alan B. Sandler view on EDGAR
- - Jeff Cislini view on EDGAR
- - Anthony Mancini view on EDGAR
- - Elizabeth M. Anderson view on EDGAR
- - Anthony Mancini view on EDGAR
- - Alan B. Sandler view on EDGAR
- - Anthony Mancini view on EDGAR
- - Stephen Michael Kelsey view on EDGAR
- - Margaret A. Horn view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where RVMD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RVMD with a 7-day demo
- RVMD on your watchlist
- Every RVMD Form 4 filing on record
- Up to 3 months of RVMD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
